Hawkins (NASDAQ:HWKN) Releases Earnings Results, Misses Estimates By $0.06 EPS

Hawkins (NASDAQ:HWKN) released its quarterly earnings data on Wednesday. The specialty chemicals company reported $0.69 earnings per share for the quarter, missing the consensus estimate of $0.75 by ($0.06), FiscalAI reports. Hawkins had a net margin of 7.95% and a return on equity of 17.42%. The firm had revenue of $244.08 million for the quarter, compared to analyst estimates of $252.51 million.

Hawkins Trading Up 0.1%

NASDAQ:HWKN traded up $0.11 on Wednesday, reaching $153.75. 95,907 shares of the stock traded hands, compared to its average volume of 119,371. The company has a current ratio of 2.43, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. Hawkins has a 1-year low of $98.30 and a 1-year high of $186.15. The company’s 50 day moving average is $143.56 and its 200-day moving average is $156.59. The firm has a market capitalization of $3.21 billion, a price-to-earnings ratio of 38.63, a price-to-earnings-growth ratio of 2.37 and a beta of 0.86.

Insider Activity at Hawkins

In other news, VP Drew M. Grahek acquired 1,587 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was bought at an average cost of $126.34 per share, for a total transaction of $200,501.58. Following the completion of the transaction, the vice president directly owned 39,640 shares in the company, valued at $5,008,117.60. This represents a 4.17% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 4.10% of the company’s stock.

Institutional Trading of Hawkins

A number of institutional investors have recently bought and sold shares of the company. Quantinno Capital Management LP raised its position in shares of Hawkins by 0.9% in the 2nd quarter. Quantinno Capital Management LP now owns 13,618 shares of the specialty chemicals company’s stock worth $1,935,000 after acquiring an additional 124 shares in the last quarter. California State Teachers Retirement System grew its stake in Hawkins by 1.2% during the second quarter. California State Teachers Retirement System now owns 18,328 shares of the specialty chemicals company’s stock worth $2,604,000 after purchasing an additional 224 shares during the period. Swiss National Bank grew its stake in Hawkins by 1.1% during the third quarter. Swiss National Bank now owns 38,388 shares of the specialty chemicals company’s stock worth $7,014,000 after purchasing an additional 400 shares during the period. Advisory Services Network LLC bought a new stake in Hawkins in the third quarter worth approximately $79,000. Finally, Alliancebernstein L.P. lifted its stake in Hawkins by 2.1% in the third quarter. Alliancebernstein L.P. now owns 21,224 shares of the specialty chemicals company’s stock valued at $3,878,000 after buying an additional 440 shares during the period. Institutional investors own 69.71% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. BWS Financial reissued a “buy” rating and set a $200.00 price target on shares of Hawkins in a research note on Monday, November 3rd. Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Finally, Zacks Research raised shares of Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Hawkins currently has a consensus rating of “Hold” and an average price target of $162.50.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.